Paper42889445PubMed
MSC-derived extracellular vesicles for spinal cord injury: inflammatory microenvironment modulation, stage-dependent repair mechanisms, and translational challenges.
Yu H and 9 others. Front Cell Neurosci, 2026.
Cite this record
ConductScience Library. MSC-derived extracellular vesicles for spinal cord injury: inflammatory microenvironment modulation, stage-dependent repair mechanisms, and translational challenges. Papers, record 42889445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MSC-derived extracellular vesicles for spinal cord injury: inflammatory microenvironment modulation, stage-dependent repair mechanisms, and translational challenges.
- Journal
- Front Cell Neurosci
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-19
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25899407 | Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. | J Extracell Vesicles | 2015 | https://conductscience.org/library/papers/25899407 | PubMed |
| 2 | 42425423 | Mesenchymal stem cell-derived small extracellular vesicles in spinal cord injury: From molecular repair mechanisms to standardized translational development. | J Neurosci Methods | 2026 | https://conductscience.org/library/papers/42425423 | PubMed |
| 3 | 21775604 | JIP3 mediates TrkB axonal anterograde transport and enhances BDNF signaling by directly bridging TrkB with kinesin-1. | J Neurosci | 2011 | https://conductscience.org/library/papers/21775604 | PubMed |
| 4 | 29669940 | Generation and testing of clinical-grade exosomes for pancreatic cancer. | JCI Insight | 2018 | https://conductscience.org/library/papers/29669940 | PubMed |
| 5 | 23647386 | Anti-apoptotic effect of microRNA-21 after contusion spinal cord injury in rats. | J Neurotrauma | 2013 | https://conductscience.org/library/papers/23647386 | PubMed |
| 6 | 42486000 | Exosome-mediated macrophage polarization: advances in immunotherapeutic paradigms and mechanisms in skeletal system diseases. | Int Immunopharmacol | 2026 | https://conductscience.org/library/papers/42486000 | PubMed |
| 7 | 31908929 | Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019). | J Orthop Translat | 2020 | https://conductscience.org/library/papers/31908929 | PubMed |
| 8 | 29848167 | Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes. | J Neurotrauma | 2019 | https://conductscience.org/library/papers/29848167 | PubMed |
| 9 | 22384132 | Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). | PLoS One | 2012 | https://conductscience.org/library/papers/22384132 | PubMed |
| 10 | 42089052 | Exosomes as regenerative therapeutics for spinal cord injury: mechanisms and clinical prospects. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42089052 | PubMed |
| 11 | 40408027 | The Intricate Relationship of Trk Receptors in Brain Diseases and Disorders. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40408027 | PubMed |
| 12 | 31405713 | MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. | Lancet Neurol | 2019 | https://conductscience.org/library/papers/31405713 | PubMed |
| 13 | 29689228 | Exosomes and Ectosomes in Intercellular Communication. | Curr Biol | 2018 | https://conductscience.org/library/papers/29689228 | PubMed |
| 14 | 28665182 | Systemic Administration of Exosomes Released from Mesenchymal Stromal Cells Attenuates Apoptosis, Inflammation, and Promotes Angiogenesis after Spinal Cord Injury in Rats. | J Neurotrauma | 2017 | https://conductscience.org/library/papers/28665182 | PubMed |
| 15 | 23699532 | BDNF-dependent recycling facilitates TrkB translocation to postsynaptic density during LTP via a Rab11-dependent pathway. | J Neurosci | 2013 | https://conductscience.org/library/papers/23699532 | PubMed |
| 16 | 31069028 | Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. | J Extracell Vesicles | 2019 | https://conductscience.org/library/papers/31069028 | PubMed |
| 17 | 29752089 | hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation. | Mater Sci Eng C Mater Biol Appl | 2018 | https://conductscience.org/library/papers/29752089 | PubMed |
| 18 | 29871522 | Microenvironment Imbalance of Spinal Cord Injury. | Cell Transplant | 2018 | https://conductscience.org/library/papers/29871522 | PubMed |
| 19 | 30611186 | Time is spine: a review of translational advances in spinal cord injury. | J Neurosurg Spine | 2019 | https://conductscience.org/library/papers/30611186 | PubMed |
| 20 | 26138677 | Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. | Cell Res | 2015 | https://conductscience.org/library/papers/26138677 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42889445
GET https://conductscience.org/api/papers/v1/42889445/references?page=2